Simplex Trading’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,100
Closed -$1K 9886
2024
Q3
$1K Sell
1,100
-7,400
-87% -$11.8K ﹤0.01% 8327
2024
Q2
$17K Buy
8,500
+2,300
+37% +$5.42K ﹤0.01% 7057
2024
Q1
$22K Buy
6,200
+3,200
+107% +$12.3K ﹤0.01% 7034
2023
Q4
$9K Buy
3,000
+700
+30% +$1.42K ﹤0.01% 7545
2023
Q3
$4K Sell
2,300
-100
-4% -$400 ﹤0.01% 7833
2023
Q2
$13K Sell
2,400
-300
-11% -$2.35K ﹤0.01% 7204
2023
Q1
$16K Buy
2,700
+1,700
+170% +$11.8K ﹤0.01% 7159
2022
Q4
$5K Sell
1,000
-2,100
-68% -$11.8K ﹤0.01% 8124
2022
Q3
$16K Buy
+3,100
New +$15.7K ﹤0.01% 7792

Other funds holding OMGA

Simplex Trading's OMGA Position: Q1 2025 in Review

Simplex Trading sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 342 shares.

Simplex Trading first reported a position in OMGA in Q1 2022 and held it in 10 quarters. The position peaked at $70K in Q3 2022. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Simplex Trading reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 342 Omega Therapeutics, Inc. Common Stock shares in Q1 2025.
  • Simplex Trading first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • Simplex Trading's Omega Therapeutics, Inc. Common Stock position peaked at $70K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.